Volpara Now Operates Under Lunit Brand, Advancing a Unified Vision for AI Cancer Intelligence
PR Newswire —
The rebranding marks the first phase of Lunit's unified global identity, connecting breast health, AI detection, and precision oncology under one name. SEOUL, South Korea, Nov. 6, 2025 /PRNewswire/ -- Lunit (KRX: 328130), a leading provider of AI for cancer diagnostics and therapeutics,...